Home - Products - Autophagy - Thrombin - H-Gly-Arg-pNA dihydrochloride

H-Gly-Arg-pNA dihydrochloride

CAS No. 125455-61-0

H-Gly-Arg-pNA dihydrochloride( —— )

Catalog No. M34903 CAS No. 125455-61-0

H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	205	Get Quote
5MG	323	Get Quote
10MG	475	Get Quote
25MG	750	Get Quote
50MG	1040	Get Quote
100MG	1377	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

H-Gly-Arg-pNA dihydrochloride
Note

Research use only, not for human use.
Brief Description

H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.
Description

H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Autophagy
Target

Thrombin
Recptor

Thrombin
Research Area

——
Indication

——

Chemical Information

CAS Number

125455-61-0
Formula Weight

424.28
Molecular Formula

C14H23Cl2N7O4
Purity

>98% (HPLC)
Solubility

——
SMILES

N=C(N)NCCC[C@H](NC(CN)=O)C(NC1=CC=C(C=C1)[N+]([O-])=O)=O.Cl.Cl
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Ozagrel

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
Thrombin

Thrombin is a trypsin-like allosteric serine protease.
Enoxaparin sodium

Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).

Sign In Join Free